The Discounted Cash Flow (DCF) valuation of Crescita Therapeutics Inc (CTX.TO) is (1.08) CAD. With the latest stock price at 0.50 CAD, the upside of Crescita Therapeutics Inc based on DCF is -318.6%.
Based on the latest price of 0.50 CAD and our DCF valuation, Crescita Therapeutics Inc (CTX.TO) is a sell. selling CTX.TO stocks now will result in a potential gain of 318.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 6.9% | 6.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (9.24) - (0.46) | (1.08) |
| Upside | -1967.3% - -192.0% | -318.6% |